Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 36 Gross Margin % is 43.70% as of Mar. 2026, which is 5% above its 10-year median of 41.44. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 14 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 78.57% on this metric.
BJSE:920656's Gross Margin % is ranked better than 78.57% of 14
companies
in the Healthcare Plans industry
Industry Median: 18.595
vs BJSE:920656: 43.18
Zhejiang Chemsyn Pharm Co had a gross margin of 43.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Zhejiang Chemsyn Pharm Co (BJSE:920656) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zhejiang Chemsyn Pharm Co had a gross margin of 43.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zhejiang Chemsyn Pharm Co Gross Margin % Related Terms
Zhejiang Chemsyn Pharm Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: Gross Margin % Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co Gross Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Gross Margin % of 43.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is near median its historical median of 41.44. Over the past decade, Zhejiang Chemsyn Pharm Co's Gross Margin % has ranged from 15.55 to 57.36. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 14 companies in the Healthcare Plans industry, placing it in the top 21.4%.
Is Zhejiang Chemsyn Pharm Co's Gross Margin % too high?
Zhejiang Chemsyn Pharm Co's current Gross Margin % of 43.70% is near median its 10-year median of 41.44. Over the past 10 years, this metric has ranged from a low of 15.55 to a high of 57.36. The Healthcare Plans industry median Gross Margin % is 18.60. Zhejiang Chemsyn Pharm Co's value of 43.70% is 135% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 14 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Gross Margin % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 14 companies for Gross Margin %. This places Zhejiang Chemsyn Pharm Co in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 18.60. Zhejiang Chemsyn Pharm Co's value of 43.70% is 135% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own Gross Margin % has ranged from 15.55 to 57.36 over the past decade. While the company's 10-year median is 41.44 vs. the industry median of 18.60, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Plans company?
The median Gross Margin % among Healthcare Plans companies is 18.60, based on 14 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current Gross Margin % of 43.70% is 135% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median Gross Margin % is 18.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current Gross Margin % is 43.70%, which is near median its own 10-year median of 41.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Gross Margin % of 43.70%. The current Gross Margin % is 43.70%, which is near median its 10-year median of 41.44 and 135% above the Healthcare Plans industry median of 18.60. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Gross Margin % is 43.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
